Home LiteratureArticle Details
PMID: 3754878 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Journal of clinical microbiology ·Vol. 23 ·No. 6 ·1986-06-00 ·Pages 1009-14

Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF

Abstract

An enzyme-linked immunosorbent assay (ELISA) with immunoaffinity-purified fusion (F) or attachment (G) glycoprotein was used to measure the serum and secretory immune responses of 18 infants and children, 4 to 21 months of age, who underwent primary infection with respiratory syncytial virus (RSV). Most of the 10 older individuals (9 to 21 months of age) developed moderate levels of serum and nasal-wash immunoglobin A (IgA) and IgG F and G antibodies. These individuals developed a moderate level of serum or nasal-wash antibodies that neutralized virus infectivity. One of the eight younger individuals (4 to 8 months of age) failed to develop an F antibody response, while three failed to develop a G antibody response. The most notable difference in the responses of the two age groups involved the titer in convalescent sera of G, F, and neutralizing antibodies which were 8- to 10-fold lower in younger individuals. Most of the younger infants failed to develop a rise in serum or nasal-wash neutralizing antibody. It is possible that the presence of maternally derived antibody in the younger infants suppressed the immune response to RSV infection, and that this accounted, in part, for the low level of postinfection antibody titer in this group. This low level and the irregular response of the infants less than 8 months of age may contribute to the severity of their initial infection and may also be responsible, in part, for their failure to develop effective resistance to subsequent reinfection by RSV.

MeSH Terms
Antibodies, Viral/analysis,biosynthesis Enzyme-Linked Immunosorbent Assay Humans Immunoglobulin A/analysis,biosynthesis Immunoglobulin A, Secretory/analysis,biosynthesis Immunoglobulin G/analysis,biosynthesis Infant Membrane Glycoproteins Nasal Mucosa/immunology Neutralization Tests Respiratory Syncytial Viruses/immunology Respiratory Tract Infections/immunology Respirovirus Infections/immunology Viral Envelope Proteins/immunology Viral Fusion Proteins Viral Proteins/immunology
Chemicals
Antibodies, Viral G protein, vesicular stomatitis virus Immunoglobulin A Immunoglobulin A, Secretory Immunoglobulin G Membrane Glycoproteins Viral Envelope Proteins Viral Fusion Proteins Viral Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Murphy B R
Graham B S
Prince G A
Walsh E E
Chanock R M
Karzon D T
Wright P F
References (35)
35 references, click to expand
  1. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.
    J Immunol. 1971 Jul;107(1):123-30 PMID: 5091954
  2. Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children.
    JAMA. 1961 May 27;176:647-53 PMID: 13692354
  3. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
    Am J Epidemiol. 1973 Oct;98(4):289-300 PMID: 4355170
  4. Clinically useful method for the isolation of respiratory syncytial virus.
    J Infect Dis. 1975 Jan;131(1):1-5 PMID: 162921
  5. Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection.
    Infect Immun. 1978 Jun;20(3):660-4 PMID: 352952
  6. The immunologic response to infection with respiratory syncytial virus in infants.
    J Infect Dis. 1978 Jul;138(1):24-32 PMID: 355574
  7. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.
    N Engl J Med. 1979 Mar 8;300(10):530-4 PMID: 763253
  8. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.
    Infect Immun. 1979 Feb;23(2):276-81 PMID: 422241
  9. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.
    J Pediatr. 1980 May;96(5):808-13 PMID: 7365579
  10. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
    J Clin Microbiol. 1981 Mar;13(3):554-60 PMID: 7240388
  11. Secretory antibody response to respiratory syncytial virus infection.
    Am J Dis Child. 1981 Nov;135(11):1013-6 PMID: 7294005
  12. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
    Infect Immun. 1982 Jun;36(3):1102-8 PMID: 7095844
  13. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
    Infect Immun. 1983 Jun;40(3):1092-5 PMID: 6852914
  14. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.
    J Virol. 1983 Jul;47(1):171-7 PMID: 6345804
  15. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.
    Infect Immun. 1983 Aug;41(2):540-5 PMID: 6874068
  16. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.
    J Gen Virol. 1983 Sep;64 (Pt 9):1867-76 PMID: 6886679
  17. Cellular and humoral immunity in recurrent respiratory syncytial virus infections.
    Pediatr Res. 1983 Sep;17(9):753-8 PMID: 6622111
  18. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.
    Infect Immun. 1984 Feb;43(2):756-8 PMID: 6363300
  19. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.
    J Gen Virol. 1984 Apr;65 ( Pt 4):761-7 PMID: 6707612
  20. Monoclonal antibodies protect against respiratory syncytial virus infection in mice.
    Immunology. 1984 May;52(1):137-42 PMID: 6201436
  21. Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay.
    J Med Virol. 1984;14(1):67-72 PMID: 6747613
  22. Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein.
    Proc Natl Acad Sci U S A. 1984 Nov;81(21):6706-10 PMID: 6093114
  23. An enzyme-linked immunosorbent assay (ELISA) for IgG and IgA antibodies to respiratory syncytial virus in low dilutions of secretions of human serum and secretions.
    J Med Virol. 1984;14(3):285-94 PMID: 6389773
  24. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 1984 Dec;81(24):7683-7 PMID: 6096849
  25. Sequence determination of the Sendai virus fusion protein gene.
    J Gen Virol. 1985 Feb;66 ( Pt 2):317-31 PMID: 2981971
  26. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    J Infect Dis. 1985 Apr;151(4):626-33 PMID: 2579169
  27. Purification and characterization of the respiratory syncytial virus fusion protein.
    J Gen Virol. 1985 Mar;66 ( Pt 3):409-15 PMID: 3838336
  28. Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins.
    J Gen Virol. 1985 Mar;66 ( Pt 3):417-32 PMID: 3919149
  29. Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.
    J Virol. 1985 Mar;53(3):976-9 PMID: 3973971
  30. Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit.
    Nucleic Acids Res. 1985 Mar 11;13(5):1559-74 PMID: 2987829
  31. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4075-9 PMID: 3858865
  32. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.
    J Infect Dis. 1985 Nov;152(5):1083-7 PMID: 4045247
  33. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus.
    Virology. 1985 Jun;143(2):569-82 PMID: 2414910
  34. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.
    Nucleic Acids Res. 1985 Nov 11;13(21):7795-812 PMID: 4069997
  35. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.
    Am J Epidemiol. 1973 Sep;98(3):216-25 PMID: 4355005
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1986-06-00
Pages
1009-14
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC268782
Subset
IM
Grants
NIAID NIH HHS · N01 AI 22507 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com